IUBio

Brain clues to attention disorder

Peter F. effectivespamblock at ozemail.com.au
Wed Dec 24 08:29:43 EST 2003


I understand that most of you clinicians *are* doing the best you can and
know how -- given all *the actually* available options.

Notwithstanding, would it in your opinion (you "orkeltatte" eller Torkel
Atte's opinion :-) be too much to ask that health-workers (but especially
importantly you at the top of "the health-working professional heap", so to
speak) *at least try* to understand the practically implementable principles
that flow from work such as very strongly exemplified by what you find
at/can dig out from: www.primaltherapy.com.?
 Or have you already been rendered too biased against even trying to
perceive the preventative practical possiblilties that in principle are
pointed-out by Primal Theory?

Yours ever hopeful,

Peter F

<orkeltatte at hotmail.com> wrote in message
news:84da9680.0312240036.54fbf491 at posting.google.com...
> Okey!
>
> Trying to leave the microcosmos just for a little while and put a
> clinical view on this topic.
> I have´nt read all threads , so if I am repeating any earlier
> discussion or point of view, please bear vith me.
>
> As a clinician , prescribing any treatment, it always come to waying
> the risks against the benefits in a long term as well as short term
> timeperspective. There are a substantial body of evidence on treating
> children diagnosed as ADDH with amphetamine and metamphetamine , where
> we find on long term follow-up , that the child has a great benefit
> with treatment regarding academic achievements, family function,
> sociability,etcetera,etcetera. as opposed to the untreated wich has a
> signifiquant risk of future criminal behavior and drugaddiction. In a
> Swedish material it has been found that 50% of the heroineaddicts
> (intravenous) was diagnosed with ADDH in adulthood. 40% of the inmates
> in prisons had a neuropsychiatric condition. and so on.
>
> The problem lies in the fact that all mechanisms on cell level and
> transmittorinteractions are not fully understood (wich this board is
> an excellent example of) and the long-term consequences on the
> immature and developing brain still are to a great extent unknown.
> Anyway it is my strong opinion that the benefits from treatment
> strongly outmatches the today known risks , and that it is morally and
> ethically  impossible to refuse treatment with these drugs.
>
> orkeltatte





More information about the Neur-sci mailing list

Send comments to us at biosci-help [At] net.bio.net